ANAPHYLAXIS. Following Vaccination of Adults. A Severe Adverse Event

Similar documents
ANAPHYLAXIS Following Vaccination. A Severe Adverse Event. Developed for the Grampians Infection Control Group (GRICG) Version 2.

Management of an immediate adverse event following immunisation

Anaphylaxis: treatment in the community

Anaphylaxis: Treatment in the Community

PROCEDURE FOR MANAGING AN ANAPHYLACTIC EMERGENCY

PRIMARY CARE PRACTICE GUIDELINES

VACCINE-RELATED ALLERGIC REACTIONS

VACCINE-RELATED ALLERGIC REACTIONS

Management of ANAPHYLAXIS in the School Setting. Updated September 2010

Allergic Reactions and Envenomations. Chapter 16

The Immunisation Service s at the Royal Children s Hospital. Sonja Elia Nurse Practitioner and Manager Immunisation

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Should a pupil show signs of a mild- moderate allergic reaction:

ANAPHYLAXIS AND EPIPEN ADMINISTRATION

Managing Medical Emergencies in a Dental Practice

Introduction to Emergency Medical Care 1

Primary Care practice clinics within the Edmonton Southside Primary Care Network.

An allergic reaction is an exaggerated response by the immune system to a foreign substance

Primary Care practice clinics within the Edmonton Southside Primary Care Network.

Anaphylaxis Independent Learning Package

Anaphylaxis 5/31/2015

Appendix (ii) Common medical emergencies in general dental practice

Recognize Anaphylaxis Symptoms

Shelley Westwood, RN, BSN

TREATMENT OF ANAPHYLACTIC REACTION WITH EPINEPHRINE

Queen City Independent School District Stock Epinephrine Policy/Protocol

Product Information BROWN SNAKE ANTIVENOM AUST R 74897

first aid information

MANAGING COMMON PRESENTATIONS OF ALLERGY IN PRIMARY CARE. Helen Bourne Consultant Immunologist

Allergy Management Policy

FAUQUIER COUNTY PUBLIC SCHOOLS Policy: Adopted: 04/10/2012 Revised: 07/23/12, 7/08/13, 08/11/14, 08/14/17 ADMINISTERING MEDICINES TO STUDENTS

Allergy Awareness & EpiPen Administration

Medical Directive. Activation Date: July 1, 2011 Review due by: December 1, Medical Director: Date Reviewed: December 1, 2016

St. Joseph s Primary School Numurkah

Managing Allergies and Anaphylaxis at School EPI-PEN TRAINING FOR SCHOOL PERSONNEL

Duration of resource: 25 Minutes. Year of Production: Stock code: VEA12045

Medical Emergencies and Current Management in Dentistry. Prof. Mark Greenwood Newcastle University

Faith Lutheran College, Redlands Faith in Christ prepared for life A I ANAPHYLAXIS POLICY T H. Last updated June 2017

EpiPen Training Module:

Signs and Symptoms Of Common Health Concerns

Bronchospasm & SOB. Kim Kilmurray Senior Clinical Teaching Fellow

GET TRAINED. A program for school nurses to train school staff to administer epinephrine using an auto-injector

Stowe School Allergy Policy

MEDICAL EMERGENCIES IN THE DENTAL PRACTICE

Emergency Treatment of Anaphylaxis Policy and Guidelines

Food allergy in children. nice bulletin. NICE Bulletin Food Allergy in Chlidren.indd 1

Package leaflet: Information for the user

Policy for the Treatment of Anaphylaxis in Adults and Children

GET TRAINED. What Would You Do? You have moments to react. Bianca 1/15/2014 GET TRAINED

Managing Illness 8/9/2010 1

CHAPTER 9. Shock National Safety Council

Allergy to: Asthma: [ ] Yes (higher risk for a severe reaction) [ ] No For a suspected or active food allergy reaction:

Appendix (i) The ABCDE approach to the sick patient

SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Epinephrine Auto-Injector Training

Managing Allergies and Anaphylaxis at School: Training for School Personnel

TREATING ALLERGIES THROUGH EDUCATION

Anaphylaxis Emergency Plan (individual)

Have you ever managed patients who have experienced an adverse reaction to transfusion?

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

First Aid Information

EMT OPTIONAL SKILL. Cell Phones and Pagers. Epinephrine Auto-injector. Course Outline 9/2017

Anaphylaxis/Latex Allergy

S:\Admin Staff\100 Administration\2010\109 Policy\Operational Plans\Anaphylaxis Policy.doc

Delaware Health and Social Services Division of Public Health Standing Orders July 22, 2017 June 30, 2018

Airway and Ventilation. Emergency Medical Response

CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAXIS IN INFANTS AND CHILDREN UNDER SIXTEEN YEARS OF AGE V3.0

Surry County Health & Nutrition Center. Medical Emergency Response Policy

ADMINISTRATIVE CHECKLIST FOR ANAPHYLAXIS

Emergency Preparedness for Anaphylaxis in School

Acute management of anaphylaxis

Murrayville Community College Anaphylaxis Policy

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection

Emergency treatment of anaphylaxis in adults: concise guidance

PATIENT INFORMATION. Auvi-Q (epinephrine injection) Auto-Injector For allergic emergencies (anaphylaxis)

Chapter 20 - Immunologic Emergencies

ACTION PLAN FOR. Difficult/noisy breathing Swelling of tongue Swelling/tightness in throat Wheeze or persistent cough ACTION FOR ANAPHYLAXIS

Epinephrine Intramuscular (IM) Injection Administration EMT Optional Scope Highlights

Pharmacist-Administered Immunizations

FLU VACCINE INFORMATION SHEET

MEDICAL EMERGENCIES HANDBOOK Last Update 1/26/2013

SCHOOL DISTRICT NO. 51 (BOUNDARY) P O L I C Y

CCSD School Nurses. Support of Students with Life Threatening Allergies

Database of Adverse Event Notifications - medicines

ANAPHYLAXIS POLICY & PROCEDURES

POLICY MANUAL Section 5 NO: Anaphylaxis/Life Threatening Medical Conditions -POLICY-

School District No. 40 Medical Alert Form

Drew University Health Service 36 Madison Avenue Madison, New Jersey Tel: Fax:

Asthma With a Slight Chance of Anaphylaxis

EMT. Chapter 10 Review

NeisVac-C Meningococcal group C polysaccharide conjugate vaccine (tetanus toxoid protein conjugate)

MENACTRA Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Medical Director: Activation Date: July 1, 2011 Review due by: December 1, 2020

belimumab (rmc) 120 mg and 400 mg powder Please read this leaflet carefully before you are given BENLYSTA.

About the immune system

Terms What is Anaphylaxis? Causes Signs & Symptoms Management Education Pictures Citations. Anaphylaxis; LBodak

EPI PEN TRAINING KAREN, RN, BSN FARGO SOUTH SCHOOL NURSE

patient group direction

Document Title: Patient Group Direction for Adrenaline (Epinephrine) 1:1000. Version No.: 07/2014. Medicines Management Committee

Where There Is No Doctor 2017

Helpful Tips for Successful Immunization

Transcription:

ANAPHYLAXIS Following Vaccination of Adults A Severe Adverse Event Developed for the Grampians Infection Control Group () Version 3.0:2018

Target audience This information package is for nurse immunisers responsible for vaccinating adults only. If you vaccinate children please refer to the Australian Immunisation Handbook for specific information on anaphylaxis management for children.

Adverse Event Following Immunisation Adverse event following immunisation (AEFI) is any untoward medical occurrence that follows immunisation Local reactions Vaccine specific reactions Program errors Coincidental effects Most AEFI are minor

Adverse Events Following vaccination: Local reactions least severe, most common Pain or redness at site of injection Systemic reactions less common Fever Allergic reactions rare but severe Anaphylactic reaction Rapid onset- usually begin within 15 minutes of vaccination but can occur within hours of vaccine administration VACCINE RECIPIENTS SHOULD REMAIN IN VICINITY OF PLACE OF VACCINATION FOR AT LEAST 15 MINUTES

Anaphylaxis Rare Can be fatal Must distinguish between anaphylaxis, convulsions and fainting If diagnosis is unclear consider anaphylaxis and administer adrenaline promptly

Vasovagal Episode (Fainting) Clinical Features Onset immediate, usually within minutes of or during administration of vaccine Skin generalise pallor, cool & clammy Respiratory normal, may be shallow but not laboured Cardiovascular bradycardia, with STRONG CAROTID pulse Hypotension usually transient, corrects in supine position or head down Neurological light-headedness, loss of consciousness, improves once supine or head down

Vasovagal Episode - Management Lie the person down If the person is unconscious, roll them on their side. Check they are breathing and have a pulse If possible, elevate the person's feet above the height of their head Loosen belts, tight clothing Offer reassurance If the person does not regain consciousness within one/two minutes seek medical advice Assess for injuries if person has fallen before lying down

Anaphylaxis Clinical Features Onset usually within 15 minutes of administration of vaccine, may be within hours Skin itchiness, generalised redness, urticaria, localised oedema of deeper layers of skin or subcutaneous tissues Respiratory cough, wheeze, stridor, tachypnoea, cyanosis, rib recession Cardiovascular tachycardia, WEAK/absent central pulse Hypotension sustained and no improvement without specific treatment Neurological severe anxiety, distress, loss of consciousness no improvement in supine position

FACE Rash, hives or welts Swelling of lips, tongue, eyes and face Think F.A.S.T. AIRWAY Difficulty breathing, swallowing or speaking THINK F.A.S.T. if signs & symptoms of serious allergic reaction then act... STOMACH (Food Allergies) Abdominal pain Vomiting TOTAL BODY Rash, swelling, weakness, paleness, sense of doom, loss of consciousness Poster concept from: www.allergyfacts.org.au Original concept: Anaphylaxis Canada

Allergic Reaction Face and lip swelling Local reaction: Swelling/redness at the site of injection

Allergic Reaction

Allergic Reaction

Anaphylaxis - Management If unconscious lie on left side and maintain airway Rapid administration of ADRENALINE If no improvement in patients condition by 5 minutes repeat dose of ADENALINE every 5 minutes until improvement occurs Administer oxygen by facemask at a high flow rate (if available) Send for assistance never leave patient alone Begin CPR if required Document event including times and doses of adrenaline administered

Adrenaline Dosage - Adult Adult dose (over 50kg) 0.5ml Or Adrenaline 1:1000 = 0.01 ml/kg body weight, up to maximum of 0.5 ml (1mL syringe should be used if drawing up small doses as this improves measurement accuracy) Deep intramuscular injection (The anterolateral thigh is the preferred site) Repeat every 5 minutes until there is clinical improvement

Observe after Recovery All cases should be observed for a minimum of 4 6 hours after apparent recovery Many allergy specialists recommend a minimum of 12 hours observation post recovery, based on evidence that severe "rebound" symptoms are observed in up to 20 % of patient with anaphylaxis after apparent early recovery. (Source: http://www.allergy.org.au)

Comparison table Vasovagal or Anaphylaxis

Reporting AEFI Any serious or unexpected adverse event should be promptly reported although no time limit has been set to report an event All events suspected of having a direct relation to vaccination can be reported Any person may report an AEFI (medical and non medical) however as much detail about the event as possible is required

Reporting AEFI Where do I report a AEFI? In Victoria all AEFI are reported to SAEFVIC 03 9345 4143 or online at www.saefvic.org.au Patients and doctors in rural, regional or outer metropolitan areas in Victoria can have an online video consultation with SAEFVIC, using a web-based system similar to Skype. Consultations are bulk-billed and there are no costs to the patient or the doctor

For further Information The Australian Immunisation Handbook 10 th Edition 2013 http://www.health.gov.au/internet/immunise/publishing.nsf/content/handbook10-home

References /Disclaimer References: Australian Government, Immunise Australia http://www.immunise.health.gov.au [accessed April 2018] Australian Government, The Australian Immunisation Handbook, 10 th Edition (2013), Canberra ACT Disclaimer: Every effort has been taken to confirm the accuracy of the information presented in this presentation, however, the authors, are not responsible for errors or omissions or for any consequences from application of the information in the presentation and make no warranty, express or implied, with respect to the contents of the publication. In view of ongoing research, changes in government regulations and the flow of other information, the information is provided on the basis that all persons undertake responsibility for assessing the relevance and accuracy of its content.

Acknowledgements Developed by: Mary Smith (2006) Regional Infection Control Consultant Grampians Department of Health Victoria Updated by: Sarah Hibberd (2014), (2018) Infection Control Clinical Nurse Consultant Djerriwarrh Health Service Bacchus Marsh Victoria Further resources can be found at http://infectioncontrol.grampianshealth.org.au (Follow the infection control links)